Genesee Capital Advisors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$201K Sell
1,368
-35
-2% -$6.34K 0.06% 165
2026
Q1
$206K Sell
1,403
-11
-0.8% -$1.79K 0.09% 128
2025
Q4
$276K Sell
1,414
-298
-17% -$71K 0.11% 107
2025
Q3
$482K Buy
1,712
+103
+6% +$26.2K 0.21% 80
2025
Q2
$352K Buy
1,609
+15
+0.9% +$2.42K 0.16% 91
2025
Q1
$223K Sell
1,594
-69
-4% -$11.2K 0.11% 106
2024
Q4
$277K Sell
1,663
-23
-1% -$4.09K 0.13% 105
2024
Q3
$287K Buy
1,686
+5
+0.3% +$724 0.14% 97
2024
Q2
$237K Buy
1,681
+5
+0.3% +$621 0.12% 103
2024
Q1
$210K Buy
+1,676
New +$192K 0.12% 110

Other funds holding ORCL

Genesee Capital Advisors's ORCL Position: Q2 2026 in Review

Genesee Capital Advisors reduced its Oracle (ORCL) stake by 2.5% in Q2 2026, selling an estimated $6.34K and leaving 1,368 shares worth $201K. The position accounts for 0.06% of the portfolio, ranked #165.

Genesee Capital Advisors first reported a position in ORCL in Q1 2024 and has held it in 10 quarters since. The position peaked at $482K in Q3 2025. 3,527 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Genesee Capital Advisors held 1,368 shares of Oracle worth $201K as of Q2 2026.
  • Genesee Capital Advisors sold 35 Oracle shares in Q2 2026, an estimated $6.34K.
  • Oracle made up 0.06% of Genesee Capital Advisors's portfolio in Q2 2026, its #165 holding.
  • Genesee Capital Advisors first reported a position in Oracle in Q1 2024 and has held it in 10 quarters since.
  • Genesee Capital Advisors's Oracle position peaked at $482K in Q3 2025.
  • 3,527 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Genesee Capital Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.